These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 815998)

  • 41. Amidolytic assay of factor V in human plasma.
    Hägglund U; Blombäck M
    Thromb Res; 1986 Jan; 41(1):79-88. PubMed ID: 3515615
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Screening for heparin binding variants of antithrombin.
    Harper PL; Daly M; Price J; Edgar PF; Carrell RW
    J Clin Pathol; 1991 Jun; 44(6):477-9. PubMed ID: 2066426
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Simplified assay for antithrombin III activity using chromogenic peptide substrate. Manual and automated method.
    Frantzen Handeland G; Abildgaard U; Aasen AO
    Scand J Haematol; 1983 Nov; 31(5):427-36. PubMed ID: 6648356
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Standardisation of a simple method for the determination of antithrombin activity.
    Frigola A
    J Clin Pathol; 1977 Sep; 30(9):881-3. PubMed ID: 915017
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparative studies on the antithrombin potency of various thrombin inhibitors, as determined by using an amidolytic method.
    Callas DD; Fareed J
    Thromb Res; 1996 Jul; 83(1):97-102. PubMed ID: 8837308
    [No Abstract]   [Full Text] [Related]  

  • 46. Amidolytic assay of thrombin bound to alpha2-macroglobulin in plasma.
    Musumeci V; Landolfi R; Bizzi B
    Haemostasis; 1977; 6(2):98-109. PubMed ID: 67984
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effect of major surgery, low doses of heparin and thromboembolism on plasma antithrombin. Comparison of immediate thrombin inhibiting capacity and the antithrombin III content.
    Bergström K; Lahnborg G
    Thromb Res; 1975 Mar; 6(3):223-33. PubMed ID: 1090031
    [No Abstract]   [Full Text] [Related]  

  • 48. A method of antithrombin estimation using plasma defibrinates with ancrod.
    Howie PW; Prentice CR; McNicol GP
    Br J Haematol; 1973 Jul; 25(1):101-10. PubMed ID: 4799764
    [No Abstract]   [Full Text] [Related]  

  • 49. Human antithrombin III. Carbohydrate components and associated glycolipid.
    Danishefsky I; Zweben A; Slomiany BL
    J Biol Chem; 1978 Jan; 253(1):32-7. PubMed ID: 618863
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prevention of the influence of fibrin and alpha2-macroglobulin in the continuous measurement of the thrombin potential: implications for an endpoint determination of the optical density.
    Rijkers DT; Wielders SJ; Béguin S; Hemker HC
    Thromb Res; 1998 Feb; 89(4):161-9. PubMed ID: 9651143
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antithrombin (heparin cofactor) assay with "new" chromogenic substrates (S-2238 and Chromozym TH).
    Abildgaard U; Lie M; Odegård OR
    Thromb Res; 1977 Oct; 11(4):549-53. PubMed ID: 72424
    [No Abstract]   [Full Text] [Related]  

  • 52. Determination of plasma heparin by polybrene neutralization.
    Nash PV; Bjornsson TD
    Anal Biochem; 1984 May; 138(2):319-23. PubMed ID: 6742408
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of a new immunoturbidimetric test (Liatest antithrombin III) for determination of antithrombin antigen.
    Antovic J; Söderström J; Karlman B; Blombäck M
    Clin Lab Haematol; 2001 Oct; 23(5):313-6. PubMed ID: 11703414
    [TBL] [Abstract][Full Text] [Related]  

  • 54. An improved method for plasma fibrinogen based on thrombin time measurement.
    Saleem A; Fretz K
    Clin Chim Acta; 1975 Jul; 62(1):131-6. PubMed ID: 1149268
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Automated enzyme assay of antithrombin.
    Cederholm-Williams SA
    Ann Clin Biochem; 1980 Jul; 17(4):183-4. PubMed ID: 7425511
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Detection of thrombin-antithrombin III complex by crossed immunoelectrophoresis.
    Sas G; Pepper DS
    Thromb Res; 1976 Jul; 9(1):95-7. PubMed ID: 960066
    [No Abstract]   [Full Text] [Related]  

  • 57. Thrombin inhibition by malignant and normal cells: a cell-bound antithrombin effect.
    Tullis JL; Honegger H; Fleischaker O; Hewitt L; Kenney D; Chao FC
    Cancer; 1981 Sep; 48(5):1177-82. PubMed ID: 7272951
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Fibrin and antithrombin consumption].
    BURNSTEIN M; GUINAND A
    Sang; 1955; 26(9):892-7. PubMed ID: 13337093
    [No Abstract]   [Full Text] [Related]  

  • 59. An immunochemical method for quantitative determination of latent antithrombin, the reactive center loop-inserted uncleaved form of antithrombin.
    Kjellberg M; Rimac B; Stenflo J
    J Thromb Haemost; 2007 Jan; 5(1):127-32. PubMed ID: 17059411
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluation of an amidolytic heparin assay method: increased sensitivity by adding purified antithrombin III.
    Teien AN; Lie M
    Thromb Res; 1977 Mar; 10(3):399-410. PubMed ID: 854877
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.